Daily Judi: Monday, December 19, 2022
Every day we scan the headlines for the best items that engage the clinical trial ecosystem, workflow solutions, and more—all the latest news you need to know. Here are today's stories:
Reuters surveys how the European Union's new medical devices regulations may effect an array of companies and devices.
Dr. Pandy Opima, of AstraZeneca, explores ways to develop diversity and inclusion standards in clinical trial recruitment. (Clinical Leader)
Gabrielle Masson details how Pfizer purchased rights to RSV therapy, sisunatovir, from LianBio for $20 million. (Fierce Biotech)
Our Culture
“We create a template so we can pull back the timelines and eliminate concerns around quality and risk—because everything’s already validated in the design. Then we can work faster with no risk to quality.”
–Jamie, Trial Delivery
About Judi
Judi speeds and improves the world's clinical trial workflows. Our cloud-based platform has 120,000 users across 168 countries. We eliminate the chaos so clinical teams can focus on the patient, rather than the process. We are a SOC 2 Type II certified collaboration platform.